Hide Board Information

Show Board Information

Angel Acquisition Cp AGEL

Board Mod: hvnsangel67

Asst Mods:

Last Post: 07/15/2014 9:15:11 PM

Board Marks: 1

Posts Today: 0

Board Views Today: 3

Angel Acquisition Cp (OTCMRKTS: AGEL) Stock Message Board

1. AGEL Company Profile

    

2. AGEL Time & Sales

    

3. AGEL Recent News

    

4. AGEL Filings

    

5. AGEL Financials

    

6. AGEL Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

9	AGEL Financials 07/15/2014 20:15:13 Angel	Emylers	07/15/2014 9:15:11 PM
8	AGEL 0.0001 Stock Charts $AGEL 1 Month Chart	chartguy89	03/05/2014 7:33:16 PM
7	AGEL Stock Charts Saturday, February 22, 2014 at	chartguy89	02/22/2014 4:12:42 AM
6	AGEL Stock Chart 0.0001 Saturday, February 8,	chartguy89	02/08/2014 2:18:05 AM
5	SEC Charges Company Officers & PennyStock	MaxShockeR	09/03/2012 2:35:31 PM
4	Thanks, Im glad they finally charged	MaxShockeR	07/22/2012 8:54:22 PM
3	Love your posts man. Keep up the good	vulken17	07/22/2012 2:28:12 PM
1	AGEL "DD" that Fooled lots of investors including	MaxShockeR	07/21/2012 1:15:16 PM

Recent Articles

• Understanding Shareholder Rights and Legal Options for Investors
• Investigation Into Shareholder Rights for Companies in Transition
• Adlai Nortye's Pioneering Cancer Therapy Presentation at Key Conference
• How Google's AI Insights Are Shaping the Future of Search
• GOL Linhas Aéreas Merges with Gol Investment Brasil for Growth
• Market Update: Ethereum and XRP Shine While Bitcoin Consolidates
• Steve Eisman Highlights Growing Economic Disconnect in America
• CoHNA Celebrates Governor's Decision Against SB509 Bill
• Forecasting Growth of Anesthesia Management Systems Until 2034
• Valuable Life Lessons From Donald Trump to His Granddaughter
• GIGABYTE Unveils Global Availability of AI TOP ATOM Supercomputer
• ASUS Unveils the Game-Changing Ascent GX10 AI Supercomputer
• Apollomics, Inc. Embraces New Leadership to Advance Oncology
• Spyre Therapeutics Focuses on $275 Million Common Stock Offering
• Spyre Therapeutics Secures Funding for Advanced Therapeutics
• Take Action: Join the Quanex Building Products Class Action
• Jasper Therapeutics Investors Invited to Join Class Action Suit
• Cytokinetics, Inc. Investors: Important Class Action Alert
• California's Allergen Disclosure Law: A New Era for Dining Safety
• Restaurants Adapt To Changing Consumer Preferences in Portions
• Peter Abt Recognized for Leadership in Energy Sector Excellence
• Anabel Fernandez: A Leader in Immigration Law Advocacy
• Celebrating John P. Lynes: Neurosurgeon Excellence Recognized
• Recognizing Anthony W. Spicel, CPP: A Leader in Finance
• Celebrating Eric G. Bosnyak: A Milestone in Leadership
• Empowering Healthcare: Dr. Chrisettia Morgan's Inspiring Journey
• Celebrating John Armellino: A Lifetime Membership Honor
• Catherine A. Oleksiw, Ph.D., PCC: Celebrating Leadership Excellence
• Record Demand Highlights Exciting Future for Business Jets
• Investors Urged to Seek Justice with Soleno Therapeutics Case
• California Sets New Standard for Allergen Awareness in Dining
• LendingTree's Doug Lebda Remembered for His Impactful Vision
• The Remarkable Growth of Oracle Stock Over 15 Years
• Unlocking the Potential of AI: The New Open Data Center Initiative
• LEQEMBI IQLIK Autoinjector: A Time Honored Innovation in Care
• Unleashing AI Potential: Meet NVIDIA's DGX Spark Supercomputer
• Important Update for Dow Inc. Investors Facing Class Action
• Value Growth of Investing in TransMedics Group: A 5-Year Journey
• Discovering the Growth of SPX Technologies Over Five Years
• Innovative Initiatives for Tomorrow's AI Data Centers
• The Bahamas Strengthens Its Fiscal Stability for Global Growth
• Rogers-O'Brien Construction Innovates with Custom AI Tool
• LEQEMBI IQLIK Autoinjector Crowned as a Top Innovation
• DiCello Levitt Investigates Firefly Aerospace for Violations
• Cepton, Inc. Investors Urged to Act Before Class Action Deadline
• Exploring the Future of Polyols Market and Its Growth
• How a Decade of Investment Transformed $1000 in Amphenol
• Important Legal News for V.F. Corporation Investors
• Exploring the Growth and Dynamics of the Polyols Market
• High Demand for Apple iPhone 17 Points to Optimistic Future